Uno K
Pharmacy, Suibarago Hospital.
Arerugi. 1993 May;42(5):656-64.
Analyses of leucocyte migration activating factor (LMAF) and leucocyte migration inhibitory factor (LMIF), and measurements of interleukin-2 (IL-2) and interferon-gamma (IFN gamma) were performed after stimulation of suspected agents in 25 patients thought to be hypersensitive to antibacterial agents in order to clarify the pathogenic mechanism. The leucocyte migration inhibition test (LMIT) was negative in 6 patients. LMAF was detected in 11 patients and LMIF in 8 patients. IL-2 values (M +/- SE) were 6.23 +/- 1.33 BRPM u/ml in the LMIT-negative group, 17.67 +/- 1.68 BRPM u/ml in the LMAF-positive group and 7.98 +/- 0.26 BRPM u/ml in the LMIF-positive group. The LMAF-positive group was found to have a significantly higher level of production of IL-2 (p < 0.005) than the other groups. Moreover, mathematical analysis revealed a positive correlation between the leucocyte migration indices and IL-2 in the LMAF-positive group (r = 0.75, p < 0.01). IFN gamma was detected in only 3 patients (16% of the LMIT-positive patients), i.e., in 2 patients in the LMAF-positive group and one patient in the LMIF-positive group. The patient in the LMIF-positive group was found to have lower IFN gamma values than the patients in the LMAF-positive group. Moreover, examination of the effects of IL-2 and IFN gamma on leucocyte migration revealed that IL-2 or IFN gamma and LMAF or LMIF were not exactly the same.(ABSTRACT TRUNCATED AT 250 WORDS)
为明确致病机制,对25名疑似对抗菌药物过敏的患者,在可疑药物刺激后进行了白细胞迁移激活因子(LMAF)和白细胞迁移抑制因子(LMIF)分析,以及白细胞介素-2(IL-2)和干扰素-γ(IFNγ)检测。6名患者的白细胞迁移抑制试验(LMIT)为阴性。11名患者检测到LMAF,8名患者检测到LMIF。LMIT阴性组的IL-2值(M±SE)为6.23±1.33 BRPM u/ml,LMAF阳性组为17.67±1.68 BRPM u/ml,LMIF阳性组为7.98±0.26 BRPM u/ml。发现LMAF阳性组的IL-2产生水平显著高于其他组(p<0.005)。此外,数学分析显示LMAF阳性组中白细胞迁移指数与IL-2之间呈正相关(r = 0.75,p<0.01)。仅在3名患者(占LMIT阳性患者的16%)中检测到IFNγ,即LMAF阳性组中的2名患者和LMIF阳性组中的1名患者。发现LMIF阳性组的患者IFNγ值低于LMAF阳性组的患者。此外,对IL-2和IFNγ对白细胞迁移的影响进行检测发现,IL-2或IFNγ与LMAF或LMIF并不完全相同。(摘要截断于250字)